Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
28 studies found for:    INFLAMMATORY BOWEL DISEASE 12
Show Display Options
Rank Status Study
1 Recruiting Cyclic Exclusive Enteral Nutrition as Maintenance Therapy for Pediatric Crohn's Disease
Condition: Crohn's Disease
Intervention: Dietary Supplement: MODULEN IBD
2 Not yet recruiting Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Disease (IBD);   Crohn's Disease (CD);   Ulcerative Colitis (UC);   Pregnancy
Intervention:
3 Unknown  Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Condition: Crohn's Disease
Interventions: Biological: Trichuris suis ova (TSO);   Biological: Placebo
4 Completed Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: mesalamine;   Drug: ALTH12-1:4;   Drug: ALTH12-2:4
5 Completed
Has Results
A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: Ustekinumab 90 mg;   Drug: Ustekinumab 4.5 mg/kg;   Drug: Placebo SC;   Drug: Placebo IV
6 Completed Monoclonal Antibody Treatment of Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: J695
7 Completed
Has Results
Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Asacol 400 mg
8 Unknown  The Effect of a Probiotic Preparation (VSL#3) Plus Infliximab in Children With Crohn's Disease
Condition: Crohn's Disease
Intervention: Dietary Supplement: VSL#3
9 Completed Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: STA-5326 mesylate
10 Recruiting IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection
Condition: HIV Reservoirs
Intervention: Other: Blood sample and recto-colic biopsies
11 Completed The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: STA-5326
12 Completed Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: STA-5326 mesylate
13 Terminated The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"
Condition: Crohn's Disease
Intervention: Drug: Mesalazine (Mesalamine)
14 Recruiting A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
Interventions: Drug: LT-02;   Drug: LT-02 Placebo
15 Active, not recruiting
Has Results
A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)
Conditions: Crohn's Disease;   Colitis;   IBD;   Inflammatory Bowel Disease
Interventions: Drug: Placebo SC;   Drug: Placebo IV;   Drug: Ustekinumab 90 mg SC q8w;   Drug: Ustekinumab 130 mg IV;   Drug: Ustekinumab 90 mg SC q12w
16 Terminated
Has Results
Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Asacol 400 mg
17 Not yet recruiting This Study Tests How BI 655130 Works in Patients With Active Ulcerative Colitis. The Study Also Tests How Well BI 655130 is Tolerated and Whether it Helps the Patients
Condition: Colitis, Ulcerative
Intervention: Drug: BI 655130
18 Completed (CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.
Condition: Ulcerative Colitis
Interventions: Drug: Budesonide MMX 6 mg Tablet;   Drug: Placebo Tablet
19 Completed A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: VB-201 160mg;   Drug: Placebo
20 Completed The Colitis Once Daily Asacol Study
Condition: Ulcerative Colitis
Intervention: Drug: mesalazine (Asacol®)

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.